Personas / Equipo Humano

Guillermo Chantada

Buscador de publicaciones

Publicaciones

  • Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Català-Mora J and Chantada G.

    Use of intra-arterial chemotherapy for retinoblastoma: results of a survey

    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY . 7(4): 726-730. Nº de citas: 41

    [doi:10.3980/j.issn.2222-3959.2014.04.26]

  • Chantada G, Fandiño AC, Schvartzman E, Raslawski E, Schaiquevich P and Manzitti J.

    Impact of Chemoreduction for Conservative Therapy for Retinoblastoma in Argentina

    PEDIATRIC BLOOD & CANCER . 61(5): 821-826. Nº de citas: 28

    [doi:10.1002/pbc.24857]

  • Taich P, Ceciliano A, Buitrago E, Sampor C, Fandino A, Villasante F, Lucena E, Romero L, Chantada G and Schaiquevich P.

    Clinical Pharmacokinetics of Intra-arterial Melphalan and Topotecan Combination in Patients with Retinoblastoma

    Ophthalmology . 121(4): 889-897. Nº de citas: 36

    [doi:10.1016/j.ophtha.2013.10.045]

  • Ottaviani D, Parma D, Giliberto F, Ferrer M, Fandino A, Davila MT, Chantada G and Szijan I.

    Spectrum of RB1 Mutations in Argentine Patients: 20-years Experience in the Molecular Diagnosis of Retinoblastoma

    OPHTHALMIC GENETICS . 34(4): 189-198. Nº de citas: 10

    [doi:10.3109/13816810.2012.755553]

  • Laurent VE, Sampor C, Solernou V, Rossi J, Gabri M, Eandi-Eberle S, de Davila MT, Alonso DF and Chantada G.

    Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA

    EUROPEAN JOURNAL OF CANCER . 49(13): 2892-2899. Nº de citas: 23

    [doi:10.1016/j.ejca.2013.04.021]

  • Chantada G, Sampor C, Bosaleh A, Solernou V, Fandiño A and de Dávila MT.

    Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.

    JAMA OPHTHALMOLOGY . 131(9): 1127-1134. Nº de citas: 24

    [doi:10.1001/jamaophthalmol.2013.260]

  • Chantada G, Luna-Fineman S, Sitorus RS, Kruger M, Israels T, Leal-Leal C, Bakhshi S, Qaddoumi I, Abramson DH and Doz F.

    SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries

    PEDIATRIC BLOOD & CANCER . 60(5): 719-727. Nº de citas: 50

    [doi:10.1002/pbc.24468]

  • Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J and Chantada G.

    Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma

    PEDIATRIC BLOOD & CANCER . 60(5): 766-770. Nº de citas: 41

    [doi:10.1002/pbc.24356]

  • Buitrago E, Del Sole MJ, Torbidoni A, Fandino A, Asprea M, Croxatto JO, Chantada G, Bramuglia GF and Schaiquevich P.

    Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma

    EXPERIMENTAL EYE RESEARCH . 108: 103-109. Nº de citas: 28

    [doi:10.1016/j.exer.2013.01.002]

  • Hesseling P, Israels T, Harif M, Chantada G and Molyneux E.

    Practical recommendations for the management of children with Endemic Burkitt Lymphoma (BL) in a resource limited setting

    PEDIATRIC BLOOD & CANCER . 60(3): 357-362. Nº de citas: 46

    [doi:10.1002/pbc.24407]